CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-14 | SINGLETON J MATTHEW Director | Option exercise 10b5-1 | +20,786 | $8.00 | $166K | 30,286 |
| 2024-08-14 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −20,626 | $57.52 | $1.2M | 9,660 |
| 2024-08-14 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −160 | $58.37 | $9K | 9,500 |
| 2024-08-14 | SINGLETON J MATTHEW Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,786 | 0 | ||
| 2024-07-30 | Lian Brian President & CEO | Sale | −65,941 | $56.95 | $3.8M | 2,404,845 |
| 2024-07-30 | Lian Brian President & CEO | Sale | −19,501 | $57.81 | $1.1M | 2,385,344 |
| 2024-07-30 | Lian Brian President & CEO | Sale | −30,417 | $58.78 | $1.8M | 2,354,927 |
| 2024-07-30 | ZANTE GREG Chief Financial Officer | Sale | −12,662 | $56.96 | $721K | 190,526 |
| 2024-07-30 | ZANTE GREG Chief Financial Officer | Sale | −2,974 | $57.71 | $172K | 187,552 |
| 2024-07-30 | ZANTE GREG Chief Financial Officer | Sale | −500 | $58.71 | $29K | 187,052 |
| 2024-07-30 | Mancini Marianna Chief Operating Officer | Sale | −14,704 | $56.98 | $838K | 365,471 |
| 2024-07-30 | Mancini Marianna Chief Operating Officer | Sale | −3,322 | $57.82 | $192K | 362,149 |
| 2024-07-29 | Lian Brian President & CEO | Grant or award | +41,000 | 2,307,453 | ||
| 2024-07-29 | Lian Brian President & CEO | Grant or award | +163,333 | 2,470,786 | ||
| 2024-07-29 | ZANTE GREG Chief Financial Officer | Grant or award | +6,667 | 181,521 | ||
| 2024-07-29 | ZANTE GREG Chief Financial Officer | Grant or award | +21,667 | 203,188 | ||
| 2024-07-29 | Mancini Marianna Chief Operating Officer | Grant or award | +10,000 | 358,508 | ||
| 2024-07-29 | Mancini Marianna Chief Operating Officer | Grant or award | +21,667 | 380,175 | ||
| 2024-05-03 | ZANTE GREG Chief Financial Officer | Option exercise 10b5-1 | +4,249 | $4.68 | $20K | 211,610 |
| 2024-05-03 | ZANTE GREG Chief Financial Officer | Option exercise 10b5-1 | +30,000 | $4.88 | $146K | 241,610 |
Page 8 of 27 · 528 trades